Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › NY › WILLISTON PARK › NORTH SHORE MEDICAL LABS INC.

NORTH SHORE MEDICAL LABS INC.

NPI: 1033281126 · WILLISTON PARK, NY 11596 · Clinical Medical Laboratory · NPI assigned 11/14/2006

$1.90M
Total Medicaid Paid
266,073
Total Claims
247,336
Beneficiaries
96
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialSHEIKH, ABID (CEO)
NPI Enumeration Date11/14/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 10,693 $21K
2019 19,187 $38K
2020 28,550 $183K
2021 52,065 $623K
2022 46,897 $360K
2023 61,508 $391K
2024 47,173 $288K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 11,446 8,259 $628K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 10,345 7,207 $177K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 12,660 12,212 $143K
86769 4,468 3,395 $109K
80050 General health panel 3,624 3,578 $69K
82607 10,462 10,328 $59K
82728 8,125 8,006 $50K
83036 Hemoglobin; glycosylated (A1C) 15,077 14,414 $49K
80061 Lipid panel 16,296 15,439 $43K
86480 1,413 1,383 $42K
84439 9,245 8,949 $36K
80053 Comprehensive metabolic panel 16,725 15,714 $32K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2,579 2,562 $30K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2,634 2,610 $27K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 5,056 2,493 $25K
84443 Thyroid stimulating hormone (TSH) 13,386 12,658 $23K
86803 4,516 4,320 $22K
83550 7,945 7,830 $21K
83540 8,174 8,054 $21K
87340 4,126 4,059 $20K
84480 7,392 7,121 $20K
84153 2,696 2,570 $19K
86706 4,162 4,108 $19K
86709 3,705 3,628 $19K
83789 2,935 2,784 $18K
86696 1,931 1,921 $16K
86704 3,432 3,391 $16K
86140 7,189 7,096 $14K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 16,729 15,598 $13K
82746 1,800 1,743 $11K
83970 407 404 $10K
86695 1,656 1,640 $8K
82043 2,935 2,910 $8K
87086 Culture, bacterial; quantitative colony count, urine 2,756 2,491 $8K
84550 3,050 3,001 $7K
81000 4,083 3,858 $7K
86592 3,136 3,025 $6K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 151 144 $4K
84154 479 471 $4K
80074 143 142 $4K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 324 323 $4K
86762 369 364 $3K
82540 1,297 1,284 $3K
86765 369 364 $3K
84403 258 245 $3K
83525 374 369 $3K
86141 354 349 $2K
87186 779 723 $2K
84156 878 869 $2K
84436 6,684 6,409 $2K
85730 536 518 $2K
86735 355 350 $2K
86038 540 524 $2K
85610 803 744 $2K
86787 298 294 $1K
87088 446 408 $1K
84146 96 96 $1K
83735 402 394 $1K
86431 436 433 $1K
84466 144 144 $998.32
82533 80 80 $925.50
84479 5,495 5,310 $751.95
85652 784 758 $632.39
80076 489 418 $483.32
84100 248 230 $465.91
82550 123 122 $417.23
86701 81 79 $365.32
80048 Basic metabolic panel (calcium, ionized) 201 179 $330.88
86304 29 29 $309.04
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 62 62 $302.25
82977 132 119 $244.10
85044 283 281 $242.89
83615 81 73 $228.81
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 54 54 $220.73
84270 43 43 $190.55
86300 16 16 $187.29
82785 41 41 $181.91
82784 41 41 $150.91
86705 125 124 $135.26
82787 41 41 $85.97
36415 Collection of venous blood by venipuncture 1,989 1,788 $75.70
84520 88 80 $60.21
84134 12 12 $58.56
83013 99 99 $56.58
84478 42 37 $54.07
82310 61 52 $48.51
82565 41 39 $34.78
80164 36 26 $30.00
82465 27 24 $27.72
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 12 12 $21.43
85027 62 57 $19.20
84481 28 25 $15.00
85007 220 173 $11.78
84155 28 26 $3.67
85009 54 52 $3.12
80321 14 14 $0.00